Tone mix
Week by week 52 weeks
Share of Ocugen, Inc. Common Stock's 139 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of May 12, 2025 · tone -100HC Wainwright Issues Pessimistic Forecast for Ocugen (NASDAQ:OCGN) Stock Price-90
- Week of May 26, 2025 · tone +100Ocugen wins rare pediatric disease status for eye disorder treatment+84
- Week of Jul 13, 2026 · tone +100Ocugen, Inc. Announces Binding Term Sheet with Roots Pharmaceutical to License OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in the Middle East and North Africa+75
- Week of Aug 17, 2026 · tone +100Ocugen, Inc. (NASDAQ:OCGN) Given Consensus Recommendation of "Moderate Buy" by Brokerages+69
- Week of Jun 2, 2025 · tone +92Ocugen, Inc. Announces Signing of Binding Term Sheet for the License of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea+63
- Week of Sep 29, 2025 · tone 0Ocugen to Present at Industry and Investor Conferences in-61
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Ocugen, Inc. Common Stock in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 2 | 0 |
| Last 30 sessions | 15 | +36 |
| Last 90 sessions | 36 | +27 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Thursday, October 29, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.manilatimes.net · 1 outletOcugen to Participate in Upcoming November Investor and Industry ConferencesNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Ocugen to Participate in Upcoming November Investor and Industry Conferences | www.manilatimes.net | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, October 22, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.manilatimes.net · 1 outletOcugen to Provide Business Update and Third Quarter 2026 Financial Results on November 4Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Ocugen to Provide Business Update and Third Quarter 2026 Financial Results on November 4 | www.manilatimes.net | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, October 15, 2026
2 headlines, average tone +99: 2 positive, 0 neutral and 0 negative. Showing all 2.
- www.rttnews.com · 1 outletOcugen Expands OCU400 Gene Therapy Reach With $255 Mln Milestone DealPositive
- www.rttnews.com · 1 outletOcugen Licenses OCU400 Gene Therapy To Roots Pharmaceutical For MENA RegionPositive
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Ocugen Expands OCU400 Gene Therapy Reach With $255 Mln Milestone Deal | www.rttnews.com | 1 | Positive |
| Ocugen Licenses OCU400 Gene Therapy To Roots Pharmaceutical For MENA Region | www.rttnews.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, October 14, 2026
3 headlines, average tone +33: 1 positive, 2 neutral and 0 negative. Showing all 3.
- www.manilatimes.net · 1 outletOcugen and Roots Pharmaceutical Complete License Agreement for OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in the Middle East and North AfricaPositive
- www.dailypolitical.com · 1 outletOcugen (NASDAQ:OCGN) CEO Shankar Musunuri Sells 468,727 Shares of Company StockNeutral
- www.tickerreport.com · 1 outletOcugen (NASDAQ:OCGN) Stock: Insider Shankar Musunuri Sells 468,727 SharesNeutral
Show the table · 3 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Ocugen and Roots Pharmaceutical Complete License Agreement for OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in the Middle East and North Africa | www.manilatimes.net | 1 | Positive |
| Ocugen (NASDAQ:OCGN) CEO Shankar Musunuri Sells 468,727 Shares of Company Stock | www.dailypolitical.com | 1 | Neutral |
| Ocugen (NASDAQ:OCGN) Stock: Insider Shankar Musunuri Sells 468,727 Shares | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Friday, October 9, 2026
1 headline, average tone -52: 0 positive, 0 neutral and 1 negative. Showing all 1.
- www.prnewswire.com · 1 outletDid Ocugen, Inc. Insiders Breach their Fiduciary Duties to Shareholders?Negative
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Did Ocugen, Inc. Insiders Breach their Fiduciary Duties to Shareholders? | www.prnewswire.com | 1 | Negative |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Ocugen, Inc. Common Stock, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.